Skip to main content

Table 3 Diagnostic performance of biomarkers alone for lung-cancer death

From: Serum and blood based biomarkers for lung cancer screening: a systematic review

Test Evaluated MSC miR-test
Sensitivity 95% (95%CI: N/A) 100% (95%CI: N/A)
Specificity 78% (95% CI: 75–80%) 73% (95% CI: 70–76%)
PPV 8% (95% CI: 5–12%) 1.1% (95% CI: N/A)
NPV 99% (95% CI: N/A) 100% (95% CI: N/A)
Positive LR 4.27 3.72